PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
August 10, 2026American Heart Journal Plus Cardiology Research and PracticeOpen Access

Mechanisms of gut microbiota metabolite-mediated gut-heart Axis in heart failure: An integrative study based on network pharmacology

View Full Paper
Ask AI
Bookmark
Share

Design

Network pharmacology study

Key result

Network pharmacology analysis identified 47 candidate targets at the intersection of heart failure and gut metabolites, with PPARG as the hub target with the most extensive connections.

Authors

FTFeng TanYCYuan ChengJYJianwei Yan

Discussion

Loading...

Member takes

Overview

Suggests gut metabolite targets in HF; hypothesis-generating and requires experimental validation before clinical consideration.

Structured PICO

P
Population
In silico databases (gutMGene, GeneCards, OMIM) for heart failure and gut metabolites
E
Exposure
Gut microbiota-derived metabolites (network pharmacology analysis)
O
Outcome
Candidate targets and pathways associated with the gut-heart axis in heart failure

This network pharmacology study identifies key genes and pathways linking gut microbiota metabolites to heart failure, providing targets for future experimental research.

Cite This Study

Tan et al. (2026) studied Heart failure. Gut microbiota-derived metabolites was evaluated on Overlapping targets of heart failure and gut metabolites. Network pharmacology analysis identified 47 candidate targets at the intersection of heart failure and gut metabolites, with PPARG as the hub target with the most extensive connections.

synapsesocial.com/papers/6a827bf894037d46bac6b2a8https://doi.org/10.1016/j.ahjo.2026.100860
View Full Paper
Ask AI
Bookmark
Share